Simon Pecha

Prognostic value of significant and non-significant coronary artery stenosis detection using MDCT for major adverse cardiac events.

Successful extracorporeal membrane oxygenation weaning after cardiac resynchronization therapy device implantation in a patient with end-stage heart failure.

Implantation of a right ventricular implantable cardioverter-defibrillator lead in the right ventricular outflow tract in a patient with Ebstein anomaly and right ventricular lead dislocation.

Concomitant surgical atrial fibrillation ablation and event recorder implantation: better monitoring, better outcome?

Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency.

Predictors for permanent pacemaker implantation after concomitant surgical ablation for atrial fibrillation.

Minimal access median sternotomy for aortic valve replacement in elderly patients.

Initial experience of pacemaker and implantable cardioverter defibrillator lead extraction with the new GlideLight 80 Hz laser sheaths.

Type A aortic dissection with situs inversus.

Rhythm outcome predictors after concomitant surgical ablation for atrial fibrillation: a 9-year, single-center experience.

Mechanically induced ventricular tachycardia by the HeartWare ventricular assist device.

Safety and feasibility of concomitant surgical ablation of atrial fibrillation in patients with severely reduced left ventricular ejection fraction.

Efficacy of prophylactic intra-aortic balloon pump therapy in chronic heart failure patients undergoing cardiac surgery.

Event recorder monitoring to compare the efficacy of a left versus biatrial lesion set in patients undergoing concomitant surgical ablation for atrial fibrillation.

Clinical experience of combined HeartWare ventricular assist device and implantable cardioverter defibrillator therapy.

Prostaglandin E2 does not attenuate adrenergic-induced cardiac contractile response.

Pulse wave analysis of the aortic pressure waveform in patients with vasovagal syncope.

Stand alone totally endoscopic epimyocardial ablation in patients with persistent atrial fibrillation and significant atrial dilatation.

Implantable loop recorder monitoring after concomitant surgical ablation for atrial fibrillation (AF): insights from more than 200 continuously monitored patients.

β 1 Adrenoceptor antagonistic effects of the supposedly selective β 2 adrenoceptor antagonist ICI 118,551 on the positive inotropic effect of adrenaline in murine hearts.

Concomitant surgical ablation for atrial fibrillation (AF) in patients with significant atrial dilation >55 mm. Worth the effort?

Myocardial tissue engineering for cardiac repair.

High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.

Coronary Sinus Lead Removal: A Comparison between Active and Passive Fixation Leads.

Laser lead extraction allows for safe and effective removal of single- and dual-coil implantable cardioverter defibrillator leads: A single-centre experience over 12 years.

Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells.

Predictors of Long-term Success After Concomitant Surgical Ablation for Atrial Fibrillation.

Bleeding risk of submuscular ICD implantation with continued oral anticoagulation versus heparin bridging therapy.

Differences in laser lead extraction of infected vs. non-infected leads.